NASDAQ · Medical - Devices

Cerus Corporation (CERS) Stock

$2.33 +0.87% NASDAQ: CERS Healthcare

Valuation

MetricValue
Price$2.33
Market Cap$469.55M
P/E Ratio-62.98
P/B Ratio6.53
P/S Ratio2.07
EPS (TTM)$0.00
52-Week High$3.47
52-Week Low$1.38
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-10.31%
ROA-3.31%
ROCE-1.35%
Gross Margin-17.48%
Operating Margin-17.48%
Net Margin-3.06%
Debt/Equity1.10
Current Ratio1.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$131.0M$162.0M$156.0M$180.0M$206.0M
Operating Profit$-49.0M$-34.0M$-30.0M$-14.0M$-9.0M
Net Profit$-54.0M$-43.0M$-37.0M$-21.0M$-16.0M
EPS$-0.32$-0.24$-0.21$-0.11$-0.08
Op Margin-37.4%-21.0%-19.2%-7.9%-4.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$237.0M$218.0M$198.0M$201.0M$222.0M
Total Liabilities$152.0M$150.0M$144.0M$144.0M$157.0M
Cash$49.0M$36.0M$12.0M$20.0M$20.0M
Borrowings$88.0M$87.0M$96.0M$98.0M$97.0M

Latest News

Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress Business Wire · Jun 17, 2026 Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M Insider Monkey · Jun 16, 2026 Cerus Corporation Closes New Debt Facility of Up to $110 Million Business Wire · Jun 8, 2026 Is BrightSpring Health Services, Inc. (BTSG) Stock Outpacing Its Medical Peers This Year? Zacks · Jun 4, 2026 Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG Insider Monkey · May 23, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-26.0M$-43.0M$11.0M$11.0M
Investing Cash Flow$12.0M$6.0M$4.0M$-11.0M$-11.0M
Financing Cash Flow$10.0M$0$1.0M$0$5.0M
Net Cash Flow$12.0M$-14.0M$-24.0M$8.0M$8.0M
Free Cash Flow$-35.0M$-28.0M$-48.0M$9.0M$9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.57
EV / EBITDA178.23
FCF Yield-0.40%
Quick Ratio1.07
Interest Coverage-0.21
Return 1Y97.93%
Return 3Y0.35%
Return 5Y-35.91%

Ownership

Insiders Held3.40%
Institutions Held73.30%
Institutions Float Held75.89%
Institutional HolderSharesReport Date
Blackrock Inc.21,575,4192026-03-31
ARK Investment Management, LLC19,161,1482026-03-31
Soleus Capital Management, L.P.10,753,7002026-03-31
Baker Bros. Advisors, LP10,008,3452026-03-31
Vanguard Capital Management LLC8,131,7782026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADMAADMA Biologics Inc $10.68 -2.47% 14.08 $2.39B 0.00%
GRFSGrifols, S.A. $7.27 -0.27% 14.60 $6.15B 1.24%
HAEHaemonetics Corporation $118.51 +2.02% 50.65 $5.39B 0.00%

About Cerus Corporation

Cerus Corporation is led by CEO William Greenman, employs 614 people, headquartered in US, publicly traded since 1997.

Cerus Corporation (CERS) stock trades at $2.33 with a market capitalization of $469.55M. The stock is valued at a negative price-to-earnings (P/E) ratio of -62.98, reflecting a net loss over the last twelve months, price-to-book of 6.53, price-to-sales of 2.07. Over the past 52 weeks the stock has ranged between $1.38 and $3.47, and currently trades 32.9% below its 52-week high.

On profitability, Cerus Corporation generates a return on equity (ROE) of -10.31% (negative, reflecting a net loss), return on capital employed of -1.35%, an operating margin of -17.48%, a net profit margin of -3.06%.

Cerus Corporation by the numbers, 2016–2025

Between 2016 and 2025 Cerus Corporation reported revenue of $37.0M rising to $206.0M, a change of +456.8% across 10 years. Compounded, revenue has grown 17.5% a year over five years, 8.3% over three, 14.4% over the last twelve months. Net profit rose to $-16.0M.

Operating margin went from -165.3% in 2016 to -4.2% in 2025, a gain of 161.0 percentage points. The most recent net margin is -3.06%. On a trailing twelve-month basis to Jun '26, revenue is $222.0M and net profit $-7.0M.

Borrowings rose from $19.0M to $97.0M, cash from operations was $11.0M in the latest year, positive in 2 of the last 10.

Return on equity has averaged -51.8% over five years, and was -25.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Cerus Corporation (CERS) — frequently asked questions

What is Cerus Corporation (CERS) stock price today?

Cerus Corporation (CERS) is currently trading at $2.33, up 0.87% today.

What is CERS P/E ratio?

Cerus Corporation's P/E ratio is -62.98. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is CERS return on equity (ROE)?

Cerus Corporation's return on equity (ROE) is -10.31%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Cerus Corporation's market cap?

Cerus Corporation has a market capitalization of $469.55M.

Does CERS pay a dividend?

Cerus Corporation is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does CERS carry?

Cerus Corporation has a debt-to-equity ratio of 1.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is CERS's profit margin?

Cerus Corporation reports a net profit margin of -3.06% — the share of revenue left after every cost, including tax and interest.

What sector is CERS in?

Cerus Corporation is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is CERS listed on?

Cerus Corporation trades on NASDAQ under the ticker CERS.

What is CERS's 52-week range?

Over the last year Cerus Corporation has traded between $1.38 and $3.47.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens CERS currently matches

On the figures above, Cerus Corporation passes the filters for 6 of our ready-made screens, among them Penny Stocks, Small Cap Stocks, Stocks Under $5. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksSmall Cap StocksStocks Under $5Stocks Under $10Stocks Under $100Stocks Under $50

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.